Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 1 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A

3(60.0%)

Early Phase 1

2(40.0%)

5Total

N/A(3)

Early Phase 1(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT04676828Not ApplicableRecruiting

Functional Lung Avoidance SPECT-guided Radiation Therapy of Lung Cancer

Role: collaborator

NCT06686667Not ApplicableCompleted

The Feasibility of Overnight Time Restricted Eating and Impact on Glucose Levels in Shift Workers

Role: collaborator

NCT04488224Early Phase 1Not Yet Recruiting

Nano-X Image Guidance: CBCT With Gravity-induced Motion

Role: collaborator

NCT04399109Not ApplicableUnknown

Evaluation of a Remote Monitoring Smartphone Application and Care Model of COVID-19 Patients in the Community (ReCOVER)

Role: collaborator

NCT04205682Early Phase 1Unknown

Cannabidiol (CBD) for the Treatment of Alcohol Withdrawal

Role: collaborator

NCT01970189Unknown

The International ITP Registry

Role: lead

All 6 trials loaded